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Background: This study aimed to investigate the antioxidative and anti-inflam-
matory effects of caffeic acid phenethyl ester (CAPE) on damage caused to cere-
bellum tissue by diffuse traumatic head trauma via biochemical, histopathologic, 
and immuno-histochemical methods.
Materials and methods: Male Sprague-Dawley (300–350 g) rats were subjected 
to traumatic brain injury with a weight-drop device (300 g/1 m weight-height im-
pact). Twenty-four adult rats were randomly divided into three equal groups of 8, 
including a control group, traumatic brain injury (TBI) group, and TBI + CAPE 
treatment group (10 μmoL/kg/i.p.). Cerebellum tissue samples taken from anterior 
lobe from all rats were taken 7 days after traumatic injury and were subjected to 
biochemical and histopathological analysis, as well as immunohistochemical ana-
lysis for platelet endothelial cell adhesion molecule-1 (PECAM-1) and phosphate 
38-mitogen-activated protein kinase (p38 MAPK). 
Results: In the TBI group, the granular layer had dilatation and haemorrhage in 
the capillary vessels and inflammatory cell infiltration around the periphery of the 
blood vessels. In the TBI + CAPE group, the small capillaries in the white matter 
were slightly dilated, there were no inflammatory cells, and dense chromatin/
granular cells were observed in the granular layer. Also in the TBI + CAPE group, 
the Purkinje cells of the ganglion cell layer had ovoid nuclei, were chromatin-
-rich, and their extensions protruded to the molecular layer. CAPE is thought to 
regulate inflammation, cell damage, and angiogenetic development by affecting 
the PECAM-1 and p38 MAPK proteins. 
Conclusions: These proteins are key modulators of endothelial integrity and 
neuroinflammation in vessels in response to endothelial damage as well as of the 
proinflammatory response in the cerebellum in response to traumatic damage. 
(Folia Morphol 2019; 78, 2: 221–229)
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INTRODUCTION
The cerebellum is vulnerable to damage from 
a variety of sources, including developmental defects, 
degenerative diseases, infectious processes, chronic 
alcoholism, trauma, and tumours [35]. Caffeic acid 
phenethyl ester (CAPE) is a flavonoid-like compound 
that is the active component of propolis, which is 
obtained from honey bee hives and has been long-
used in traditional medicine. It has many protective 
properties, including antioxidant, anti-inflammatory, 
anti-carcinogenic, antiviral, neuroprotective, and im-
munomodulation [3]. Research in a number of trau-
matic brain injury (TBI) animal models has shown that 
pathophysiological changes in the cortex, thalamus, 
and hippocampus contribute to motor and cognitive 
disorders. Impairments in motor function, coordina-
tion, and cerebellar function are common outcomes 
of TBI [36]. Some of the classically described conse-
quences of direct traumatic injury to the cerebellum 
are hypotonia, ataxia, dysmetria, tremor, and vertigo 
[38]. Cells from various brain regions respond dif-
ferently to mechanical injury and it is known that 
the Purkinje neurons are the cells most affected by 
cerebellar trauma [4].
Among the many signalling pathways that re-
spond to mitogens and stress factors, mitogen-ac-
tivated protein kinase (MAPK) family members are 
crucial for cell repair by regulating the activities of 
nuclear transcription factors [43, 53, 61]. There are 
three known types of MAPKs: ERKs, SAPK/JNKs and 
p38 MAPKs. Initially, ERKs were found to be important 
for cell survival, SAPK/JNKs and p38 MAPKs were more 
likely to be stressed and thus play a role in apopto-
sis [27, 28, 52, 57]. The magnitude of the balance 
between ERK and SAPK/JNK/p38 MAPK activation 
is assumed to be a key to whether cells continue to 
survive or whether apoptosis has entered. However, 
many researchers have recently shown that the regu-
lation of apoptosis by MAPKs is more complex than 
originally thought [11, 27, 33, 52]. Mitogen-activated 
protein kinases are a highly conserved family of ser-
ine/threonine protein kinases involved in a variety of 
fundamental cellular processes such as proliferation, 
differentiation, motility, stress response, apoptosis, 
and survival. Conventional MAPKs include the extra-
cellular signal-regulated kinase 1 and 2 (Erk1/2 or 
p44/42) [22, 48], the c-Jun N-terminal kinases 1-3 
(JNK1-3)/stress activated protein kinases (SAPK1A, 1B, 
1C) [63, 65], the p38 isoforms (p38a, b, g, and d), and 
Erk5 [21, 44]. The lesser-studied, atypical MAPKs in-
clude Nemo-like kinase (NLK), Erk3/4, and Erk7/8 [20]. 
Experimental studies suggest that the phosphate 
38 mitogen-activated protein kinase signalling path-
way plays a major role in ischaemia-reperfusion in-
jury. An increase in p38 MAPK expression in kidney, 
liver, vascular and myocardial cells and pulmonary 
ischaemia-reperfusion models has been reported 
[2, 40, 50, 62]. Additionally, it has been reported that 
MAPK participates in the control of complex cellular 
processes, such as gene expression, synaptic plastic-
ity in the nervous system, cell differentiation, cell 
proliferation, cell death, and inflammation [20, 31]. 
The MAPK pathway is an evolutionarily conserved 
mechanism of transducing external stress and injury 
to internal cellular responses; these responses play 
a major role in the balance between cell survival and 
cell death [55, 58]. Platelet endothelial cell adhesion 
molecule-1 (PECAM-1) is a restricted receptor in blood 
and vascular cells [39]. 
There are five members of the immunoglobu-
lin superfamily. It has been shown that intracellu-
lar adhesion molecule-1 and -2 (ICAM-1, ICAM-2), 
vascular adhesion molecule-1 (VCAM-1), PECAM-1, 
mucosal vascular addressing cell adhesion molecule-1 
(MAdCAM-1). PECAM-1 has been reported to play an 
important role in endothelial cells and in leukocyte 
adhesion to transduction. MAdCAM-1, a ligand of 
L-selectin and a4P7 integrin, has been reported to 
play a key role in the selective targeting of lympho-
cytes [17, 47]. Furthermore, it has also been shown 
that ICAM-1, VCAM-1 and PECAM-1 serve as signal 
transducers not only for the transendothelial migra-
tion of leukocytes but also for inducing endothelial 
signalling and influencing the progression of neuro-
inflammation [18]. Among the molecules known to 
(secondarily) activate the integrins are the chemokines 
and PECAM-1, CD31 or endoCAM. Once a leukocyte 
binds to endothelium via an integrin-immunoglobulin 
(Ig) superfamily (IgSF) interaction, it “searches” for 
junctions between endothelial cells, first squeesing 
between these potential discontinuities, and then 
penetrating the underlying basement membrane to 
reach the tissues [42, 64]. Mouse CD31 has also been 
isolated and found to be 63% identical at the aa 
level to human CD31 [59]. While monoclonal anti-
bodies to CD31 are reportedly species specific [59], 
polyclonal antibodies to CD31 seem to show species 
cross-reactivity [34]. PECAM-1 plays a critical role in 
damage recovery after pathological conditions. The 
function of PECAM-1 in endothelial cells in the context 
of inflammation and apoptosis has been investigated 
[29, 56]. It is not known that PECAM-1 is exercised on 
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neurons or glia [13]. In the brain, PECAM-1 has been 
reported to be exclusively in cerebral endothelial cells 
forming the blood-brain barrier [30].
The current study aimed to investigate the anti-
oxidative and anti-inflammatory effects of CAPE on 
damage caused to the cerebellum tissue by diffuse 
traumatic head trauma via biochemical, histopatho-
logic, and immunohistochemical methods.
MATERIALS AND METHODS
Animals
Every single surgical methodology and the con-
sequent care and healing of the animals utilised as 
a part of this investigation were in strict understand-
ing with the National Institutes of Health (NIH Pub-
lications No. 8023, revised 1978) rules for animal 
care. All techniques performed in this examination 
were approved by the Ethics Committee for Animal 
Experimentation of the Faculty of Medicine at Di-
cle University, Turkey (Protocol number: 2017-32). 
Twenty-four male Sprague-Dawley rats (300–350 g) 
were maintained under 23 ± 2°C and 12 h light/dark 
cycles with ad libitum access to standard pelleted 
food and water.
All rats toward the finish of the analysis were 
healthy and no distinction in nourishment/water con-
sumption and body weight pick up amongst experi-
mental and control rats were noticed. The rats were 
divided into three equal groups as control, trauma 
(TBI), and trauma (TBI) + CAPE.
Traumatic brain injury model
Sedation procedure. The animals were anes-
thetised via an intraperitoneal injection of 5 mg/kg 
xylazine HCl (Rompun, Bayer HealthCare AG, Ger-
many) and 40 mg/kg ketamine HCl (Ketalar, Pfizer Inc., 
USA) [45], after which they were allowed to breathe 
spontaneously.
Control group. Isotonic saline solution (an equal 
volume of CAPE) was administered i.p. for 7 days.
TBI group. The diffuse brain injury model de-
scribed by Marmarou et al. [32] was used Briefly, 
a trauma device dropped a constant weight (300 g) 
from a specific height (1 m) through a tube, inducing 
mild trauma. Following trauma, the rats’ cerebellum 
tissues were removed. 
TBI + CAPE group. 15 min following injury, the 
rats were given CAPE (10 μmoL/kg/i.p) intraperito-
neally every day for 7 days [26]. At the end of the 
study, animals  were  sacrificed and cerebellum tis-
sues were removed. Blood  samples were collected 
from the inferior vena cava for serum biochemical 
markers  determination in all groups. In this way, 
MDA, SOD, CAT, and GSH-x values were measured 
biochemically. And, cerebellum tissue taken from 
anterior lobe was extracted, fixed in a 10% formalin 
solution, and embedded in paraffin blocks for histo-
pathologic examination in all groups. Sections (5 μm 
thick) were obtained from paraffin blocks and stained 
with haematoxylin and eosin (H&E).
Immunohistochemistry method
Antigen retrieval process was performed in citrate 
buffer solution (pH 6) two times first 5 min, later 
4 min boiled in microwave oven at 700 W (Bosch®). 
They were allowed to cool to room temperature for 
20 min and washed in distilled water for 5 min two times. 
Endogenous peroxidase activity was blocked in 0.1% 
hydrogen peroxide [K-40677109,64271 hydrogen 
peroxide (H2O2), Dortmudt + Germany, MERCK] (3 mL 
30% hydrogen peroxide (H2O2) + 27 mL methanol) 
for 10 min. Ultra V block (Histostain-Plus Kit, Invitro-
gen, Carlsbad, CA) was applied for 8 min prior to the 
application of primary antibodies p38 MAPK mouse 
monoclonal, 1/100 and PECAM-1 mouse monoclonal, 
1/100 for overnight. Secondary antibody (Histostain-
Plus Kit, Invitrogen, Carlsbad, CA) was applied for 
20 min. Slides then were exposed to streptavidin-perox-
idase for 25 min. Diaminobenzidine (DAB, Invitrogen, 
Carlsbad, lot: HD36221, Thermo Fischer, Fremont, CA, 
USA) was used as a chromogen. Control slides were 
prepared as mentioned above but omitting the prima-
ry antibodies. After counterstaining with haematoxy-
lin (product number: HHS32 SIGMA, Haematoxylin 
Solution, Harris Modified, Sigma-Aldrich, 3050 Spruce 
Street, Saint Louis, MO 63103, USA), washing in tap 
water for 3 min and in distilled water for 2 × 3 min, 
the slides were mounted with Entellan® (lot: 107961, 
Sigma-Aldrich, St. Louis, MO, United States).
Malondialdehyde and glutathione peroxidase  assays
Malondialdehyde (MDA) levels and glutathione 
peroxidase (GSH-Px) activities were determined in 
the cerebellum of each rat, and the average values 
of each group were calculated. Each cerebellum 
sample was prepared as a 10% homogenate (ac-
cording to weight) in 0.9% saline using a homog-
enizer on ice. Then, the homogenate was centri-
fuged at 2000 rpm for 10 min, and the superna-
tant was collected. MDA levels were determined 
using the double heating method of Draper and 
Hadley [14]. MDA is an end product of fatty acid 
224
Folia Morphol., 2019, Vol. 78, No. 2
peroxidation that reacts with thiobarbituric acid 
(TBA) to form a coloured complex. Briefly, 2.5 mL 
of TBA solution (100 g/L) was added to 0.5 mL of ho-
mogenate in a centrifuge tube, and the tubes were 
placed in boiling water for 15 min. After cooling 
with flowing water, the tubes were centrifuged at 
1000 rpm for 10 min, and 2 mL of the supernatant 
was added to 1 mL of TBA solution (6.7 g/L); these 
tubes were placed in boiling water for another 15 min. 
After cooling, the amount of TBA-reactive species was 
measured at 532 nm, and the MDA concentration 
was calculated using the absorbance coefficient of 
the MDA–TBA complex. MDA values were expressed 
as nanomoles per gram (nmol/g) of wet tissue.
The GSH-Px activity was measured by the method 
of Paglia and Valentine [37]. An enzymatic reaction was 
initiated by the addition of hydrogen peroxide (H2O2) 
to a tube that contained reduced nicotinamide adenine 
dinucleotide phosphate, reduced glutathione, sodium 
azide, and glutathione reductase. The change in absorb-
ance at 340 nm was monitored by spectrophotometry. 
Data were expressed as U/g protein.
Measurement of superoxide dismutase activity
Total superoxide dismutase (SOD) activity was 
determined with a SOD detection kit (RANSOD kit, 
Randox Co., UK) according to the manufacturer’s 
instructions. SOD accelerates the conversion of 
the toxic superoxide (produced during oxidative 
energy processes) to hydrogen peroxide and mo-
lecular oxygen. This method employs xanthine and 
xanthine oxidase to generate superoxide radicals 
that react with 2-(4-iodophenyl)-3-(4- nitrophenol)-
5-phenyltetrazolium chloride (INT) to form a red 
formazan dye. The SOD activity is measured by the 
degree of inhibition of this reaction. One unit of 
SOD causes 50% inhibition of the rate of reduction 
of INT under the assay’s conditions. Absorbance 
measurements were taken at 505 nm, and SOD 
levels were determined through a standard curve 
and expressed as U/mg protein [49].
Measurement of catalase activity
Tissue catalase (CAT) activity was assayed spectro-
photometrically by monitoring the decomposition of 
H2O2 using the procedure of Aebi [1]. Briefly, 0.5 mL 
of 30 mM H2O2 in 50 mM phosphate buffer (pH 7.0) 
was added to 1 mL of tissue supernatant (diluted 
1:10), and the consumption of H2O2 was followed 
spectrophotometrically at 240 nm for 2 min at 25oC. 
The molar extinction coefficient was 43.6 L/mol per 
cm for H2O2. CAT activity was expressed as mmol H2O2 
consumed/min per mg tissue protein.
Statistical analysis 
All of the statistical analyses for this study were 
carried out using GraphPad Prism 4.0 software 
(GraphPad Software, 2003, San Diego, CA, USA). All 
data are presented as mean ± standard deviation 
(SD). Groups of data were compared with an analysis 
of variance (ANOVA) followed by Tukey’s multiple 




The following biochemical parameters were com-
pared between groups (Fig. 1).
Tissue malondialdehyde levels 
Malondialdehyde values in the trauma (TBI) group 
were significantly higher than those of the control 
group (p < 0.001), while the TBI + CAPE group had 
significantly lower levels than those of the trauma 
(TBI) group (p < 0.001).
Tissue glutathione peroxidase levels 
Tissue glutathione peroxidase levels of the control 
group were significantly higher than those of the trau-
ma group (p < 0.001), while those of the TBI + CAPE 
group were also significantly higher than those of 
the trauma group (p < 0.001).
Superoxide dismutase levels
Tissue SOD levels of the control group were signifi-
cantly lower than those in the trauma group,  while 
those of the TBI + CAPE group were significantly 
higher than those of the trauma group (p < 0.001).
Catalase levels
Tissue CAT levels in the control group were signifi-
cantly lower than those of the trauma group (p < 0.001), 
while those of the TBI + CAPE group were significantly 
higher than those of the trauma group (p < 0.001).
Histological findings
In the control group, the Purkinje cells of the 
ganglion cell layer were in a horizontal and fibrillar 
structure. In the glomerular areas, the Purkinje cells 
were arranged regularly in a granular layer, and the 
microglia and basket cells were scattered diffusely 
in the molecular layer. In the granular layer of the 
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nuclei with chromatin-rich extensions protruding to 
the molecular layer. Diffused microglia and basket 
cells were scattered in the molecular layer.
Immunohistochemical findings
In the control group, p38 MAPK expression was 
observed in some Purkinje cells of the ganglion cell 
layer and in the basket cells of the molecular layer. 
The TBI group had positive expression of p38 MAPK 
in inflammatory cells around the blood vessels in the 
granular layer and in the molecular layer boundary. 
p38 MAPK expression also was seen in the glial cells 
and in some apoptotic Purkinje cells. In the TBI + CAPE 
group, p38 MAPK was expressed in the Purkinje cells, 
but was not expressed in the small granular cells of 
the granular layer. There was no p38 MAPK expres-
sion in the microglia and basket cells. The control 
group had no PECAM-1 expression in the microglial 
cells and endothelial cells of the capillary vessels in 
the molecular layer; however, PECAM-1 expression 
was positive in the Purkinje cells. In the TBI group, 
PECAM-1 expression was positive in the endothelial 
cells of the dilated blood vessels between the gan-
glion layer and the granular layer, in inflammatory 
cells, as well as in some degenerate Purkinje cells. 
Expression of PECAM-1 was observed in the microglial 
and basket cells and in the degenerative fibres in the 
molecular layer. In the TBI + CAPE group, there was 
no PECAM-1 expression in the microglial and basket 
cells or in the endothelial cells of some dilated vessels 
in the molecular layer; however, PECAM-1 expression 
was positive in the Purkinje cells (Fig. 2). 
DISCUSSION
Traumatic brain injury usually results in severe 
shock to the head and/or body. A minor traumatic 
brain injury can lead to the transient dysfunction 
of brain cells. Previous studies have shown that 
a variety of pathological factors (e.g., oxidative stress, 
the inflammatory response, and apoptosis) are in-
volved in secondary brain injury following traumatic 
brain injury. Early interventions to reduce the level of 
oxidative stress and the extent of the inflammatory 
response can significantly reduce the extent of trau-
matic brain injury [19]. Activated microglia cells serve 
as cellular cleaners to alleviate traumatic damage and 
promote wound healing. It has been reported that 
these numbers may increase in cases of Purkinje cell 
damage [25]. 
trauma group, there was dilatation and haemorrhage 
in the capillary vessels as well as inflammatory cell 
infiltration around the periphery of the blood ves-
sels. Degenerative changes in the Purkinje cells (i.e., 
pyknosis in some of the nuclei) were observed in the 
ganglion cell layer. In the TBI + CAPE group, the small 
capillaries were slightly dilated in the white matter. 
There were no inflammatory cells, dense chromatin/
granular cells were observed in the granular layer, and 
the Purkinje cells of the ganglion cell layer had ovoid 
Figure 1. Biochemical results relevant to the study groups;  
A. MDA; B. GSH-Px; C. SOD; D. CAT. Abbreviations — see text.
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Figure 2. A. Control group. Purkinje cells in horizontal view, fibrillar structure and granular cells regular, basket in the molecular layer and microglia cells 
diffuse appearance. H&E staining, bar 50 µm; B. Trauma group. Capillary dilatation of veins and haemorrhage and inflammatory cell infiltration around 
blood vessels (yellow arrow), Degenerative changes in pyknotic Purkinje cells in some nuclei of the ganglion cell layer (red arrow), H&E staining, bar 
50 µm; C. Trauma + CAPE group. Small dilation of small capillaries in white matter (yellow arrow). There are no inflammatory cells, dense chromatin 
cells in the granular layer, Purkinje cell of the ganglion cell layer, nuclei oval and chromatin rich appearance, and microglia and basket cells (red arrow). 
H&E staining, bar 50 µm; D. Control group. p38 MAPK expression in some Purkinje cells of ganglion cell layer and in the basket cells of the molecular 
layer (yellow arrow). p38 MAPK immunostaining, bar 50 µm; E. Trauma group. Positive expression of p38 MAPK in inflammatory cells around the blood 
vessels in the granular layer and molecular layer (red arrow), also positive p38 MAPK expression in glial cells and some apoptotic Purkinje cells (yellow 
arrow). p38 MAPK immunostaining, bar 50 µm; F.  Trauma + CAPE group. p38 MAPK expression in Purkinje cells (yellow arrow), but not expression 
in small granular cells of granular layer. Negative p38 MAPK expression in microglia and basket cells p38 MAPK (red arrow), p38 MAPK immunostain-
ing, bar 50 µm; G. Control group. PECAM-1 expression negative in microglial cells and endothelial cells of the capillary vessels in the molecular layer 
(red arrow), positive PECAM-1 expression in Purkinje cells (yellow arrow). PECAM-1 immunostaining, bar 50 µm; H. Trauma group. Positive PECAM-1 
expression in the endothelial cells of dilated blood vessels between the ganglion layer (red arrow), the granular layer, in inflammatory cells and in some 
degenerate Purkinje cells (yellow arrow), expression of PECAM-1 in microglial and basket cells and degenerative fibres in the molecular layer. PECAM-1 
immunostaining, bar 50 µm; I. Trauma + CAPE group. Negative PECAM-1 expression in microglial and basket cells and endothelial cells (red arrow), 
positive PECAM-1 expression in Purkinje cells (yellow arrow). PECAM-1 immunostaining, bar 50 µm. Abbreviations — see text.
In TBI models, regional specific cerebellar Purkinje 
cell injury and/or loss are important features that are 
known to cause cerebellar damage, including a distinct 
spatial regeneration of glia and traumatic axonal dam-
age [38]. Fukuda et al. [16] examined an injury caused 
by frontoparietal cortex lateral fluid percussion at 
1 day and 7 days after injury. At both time points, they 
reported death of Purkinje cells in the cerebellar vermis.
Traumatic brain injury causes glial cell activa-
tion in the cerebellum, and changes in the Purkinje 
cells are important for determining the extent of 
damage. Following selective and diffuse TBI, the 
cerebellum exhibits pathological changes, including 
selective cell loss, altered metabolism, and white 
matter damage [38, 46]. Damage to the Purkinje 
cells is considered an indicator of TBI [25]. In our 
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current study, the TBI group had dilatation in the 
capillary vessels and inflammatory cell infiltration 
around the haemorrhage in the granular layer. The 
Purkinje cells revealed degenerative changes with 
some pyknotic nuclei in the ganglion cells. In the 
TBI + CAPE group, it was observed slightly dilated 
small capillaries (especially in white matter), and 
the granular cells were chromatin-rich with no in-
flammation. The Purkinje cells in the ganglion layer 
have chromatin-rich, oval-shaped nuclei, and their 
cytoplasmic extensions extend into the molecular 
layer. In addition, it was seen small and diffuse 
microglia and basket cells. In the ganglion cell 
layer, the nuclei of the Purkinje cells were ovoid and 
chromatin-rich, and their extensions protruded to 
the molecular layer. Microglia and basket cells were 
diffuse through the molecular layer.
Caffeic acid phenethyl ester has been reported 
to block many inflammatory agents (primarily tu-
mour necrosis factor alpha) by blocking nuclear 
factor kappa B (NF-kB) and oxygen radicals. It has 
also been shown that CAPE inhibits apoptosis in 
inflammatory cells independent of glucocorticoid 
receptors [10]. To determine the molecular effects 
of CAPE, it was investigated changes in p38 MAPK 
and PECAM-1 expression in cerebellum tissue in 
traumatic brain injured rats. Most mRNAs coding 
for inflammatory response genes are unstable and 
stabilised by the p38 MAPK pathway [5, 54]. It is 
known that microglia respond quickly (30 min) and 
migrate immediately to the wound centre. MAPK 
p38a helps to bind inflammatory stimuli in the mi-
croglia in response to cellular activities. Sustained 
activation of p38a MAPK was observed in activated 
microglia in the brain after cerebral brain ischaemia 
[24]. Furthermore, Haines et al. [20]. revealed that 
MAPK signalling pathways regulate myelination. In 
our current study’s TBI group, p38 MAPK was ex-
pressed in the inflammatory cells around the blood 
vessels in the granular layer and in the molecular 
layer boundary. Additionally, positive p38 MAPK 
expression was seen in the glial cells and in some 
apoptotic Purkinje cells. Results of the TBI + CAPE 
group revealed that p38 MAPK was not expressed 
in the small granular cells of the granular layer or 
in the microglial and basket cells. However, the 
Purkinje cells positively expressed p38 MAPK. It 
was hypothesized that CAPE regulates the common 
inflammatory response observed after cerebellum 
injury, thus leading to re-activation of the microglial 
and Purkinje cells (Fig. 2E, F).
Vascular endothelial cells that cross the endothe-
lial cell-cell junction during inflammatory processes 
have been shown to play an important role in vascular 
regulation. These cells have the ability to modulate 
PECAM-1 intracellular signalling processes [39, 60]. 
During recovery of ischaemic damage, PECAM-1 
has been shown to regenerate angiogenic and anti-
apoptotic isoforms, as well as repair and remodel 
the damaged blood-brain barrier [12, 15]. PECAM-
1-mediated activation of the PI3K/Akt pathway up-
regulates NF-kB-mediated transcription to facilitate 
angiogenesis, cell survival/growth, and the recovery 
of the endothelial cell barrier [8, 9]. Hwang et al. [23] 
observed that transient ischaemia produced in gerbils 
by 5-min occlusion of both common carotid arteries 
results in a significant increase of PECAM-1 immuno-
reactivity and protein level in hippocampus proper. 
And, they reported that PECAM-1 immunoreactivity 
in post-ischaemic group was significantly increased 
by 4 days after ischaemic insult. Rosenblum et al. 
[41] suggested that anti-PECAM-1 treatment may be 
effective in inhibiting the in vivo inhibition of plate-
let adhesion/aggregation at the site of endothelial 
injury in brain arterioles. Vaporciyan et al. [51] have 
shown that human PECAM-1 antibody cross-reacting 
with rat PECAM-1 can block the in vivo accumulation 
of rat neutrophils in the peritoneal cavity and the 
alveolar part of the lung. The authors of this trial 
also suggested that PECAM-1 might be a potential 
therapeutic target. TBI may be expected to increase 
the expression of PECAM-1 on vascular endothelium 
in the traumatised brain, which is constantly followed 
by an acute inflammatory response. However, Carlos 
et al. [7] showed that PECAM-1 expression remained 
unchanged in a rat model.
CONCLUSIONS
It was hypothesized that PECAM-1 expression 
contributes to the development of angiogenesis af-
ter endothelial damage. In addition, it was thought 
that CAPE administration inhibits the progression of 
the inflammatory reaction in endothelial cells, which 
was initially induced by proinflammatory processes. 
CAPE administration is thought to regulate inflam-
mation, cell damage, and angiogenetic development 
by affecting the PECAM-1 and p38 MAPK proteins. 
These proteins are key modulators of endothelial in-
tegrity and neuroinflammation in vessels in response 
to endothelial damage, and are key regulators of the 
proinflammatory response occurring in the cerebel-
lum in response to traumatic damage.
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